Clinical Trials in Washington

Showing 6281-6300 of 7,241 trials

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

NCT00046384

The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with acute symptoms of Bipolar Disorder.

Bipolar I Disorder

Otsuka Pharmaceutical Development & Commercialization, Inc.Started Jun 2002

Scottsdale, Arizona, United States • Little Rock, Arkansas, United States • Chula Vista, California, United States +11 more locations

COMPLETEDPhase 336 miles

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

NCT00095745

This trial is a 52-week safety study to evaluate the safety of adjunctive aripiprazole in outpatients with major depressive disorder who have experienced an incomplete response to an ongoing antidepressant trial.

Major Depressive Disorder

Otsuka Pharmaceutical Development & Commercialization, Inc.1,002 participantsStarted Sep 2004

Mesa, Arizona, United States • Peoria, Arizona, United States • Beverly Hills, California, United States +55 more locations

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

Find Trials by Condition in Washington

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer

Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy

Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum

Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy

A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)

Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

S9624 Ifosfamide in Treating Patients With Meningeal Tumors